title: [Endolymphatic therapy in the treatment of primary delimited melanoblastoma of the skin].
abstract: The results of treatment of 1128 patients with the body and extremities skin melanoma were analyzed. The increase of five-year survival index in patients with the tumor of T1-4 N0M0 stage by 11.4% was promoted by the postoperative adjuvant endolymphatic chemotherapy application. The dacarbasin endolymphatic infusion together with recombinant interferon laferon have permitted to increase the survival index of patients by 15.4%.
authors.forename: S I
authors.initials: SI
authors.lastname: Korovin
mesh_terms: D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001132:Arm; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D007866:Leg; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D011182:Postoperative Care; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Endolimfaticheskaia terapiia v lechenii pervichno-ogranichennoĭ melanoblastomy kozhi.